Video

Selection and use of the non-anti-TNF biologic therapies: Who? When? How?

08/15/2018

Related Content

Vascular Disease
William E. Boden, MD
Vascular Disease
William E. Boden, MD, on a New Risk Score for Mortality and Myocardial Infarction in Patients With Stable Coronary Artery Disease: The COURAGE Risk Prediction Tool
06/24/2016
According to William Boden, MD, the COURAGE Risk Prediction Tool is one of the most important developments to come from the COURAGE Trial. In this video, Dr Boden explains how the the tool works and what...
06/24/2016
Gastroenterology
video
Gastroenterology
2015 Advances in Inflammatory Bowel Diseases
08/08/2018
How can we better manage common extraintestinal manifestations of IBD, and when should we refer patients to a specialist?
08/08/2018
Treatment
Treatment
Treating HCV: What’s Coming Up the Therapeutic Pipeline?
04/09/2015
David R. Nelson, MD, discusses future developments to HCV treatment strategies and methods, and how they will affect the standard of care.
04/09/2015
Myocardial Infarction
Myocardial Infarction
Cardiac Function Improves With Stem Cell Therapy After MI
11/24/2015
Intracoronary artery infusion of autologous stem cells after primary PCI or thrombolysis for acute myocardial infarction improves left ventricular ejection fraction and left ventricular volumes, according...
11/24/2015
Gastroenterology
Gastroenterology
What Factors Influence Choice of 1st Therapy in IBD: How Can We Predict Response & Be Smarter?
07/31/2018
07/31/2018